Journal profile · SUBSTANCE ABUSE
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
ISSN 0095-2990 · eISSN 1097-9891 · Informa Healthcare · UNITED STATES
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.65; JCR Q2 (journal website); hybrid open access; APC about USD 3,850; median 187 days to acceptance (88 articles, last 24 months); acceptance rate 30% (journal website); 80 articles in 2025; indexed in SCIE, SSCI and Scopus.
Scope
Aims, scope and focus
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE is published by Informa Healthcare and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Substance Abuse Treatment and Outcomes, Opioid Use Disorder Treatment and Neurotransmitter Receptor Influence on Behavior, together about 44.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The American Journal of Drug and Alcohol Abuse (AJDAA) is an international, interdisciplinary journal that is published six times per year. AJDAA provides a venue for researchers to disseminate clinically relevant research findings and innovative perspectives in the field of addiction. Topics published in AJDAA span preclinical to population-based analyses, including applied methodology, neurobiology, behavioral science, treatment, epidemiology, and public policy. The manuscripts generally present original data analyses or quantitative/narrative reviews of timely developments in our field. Manuscripts exploring behavioral addictions are encouraged. Reviews and Perspectives of emerging fields are given priority consideration. Papers are published on an ongoing basis. Areas of particular interest include: basic mechanisms novel research methodologies pharmacological, and social interventions, including innovative modalities public health policy Authors can choose to publish gold open access in this journal. Read the Instructions for Authors for more information on how to prepare and submit your manuscript. AJDAA Call for Papers: Latest Developments in Addiction Science The American Journal of Drug and Alcohol Abuse (AJDAA) invites submissions for consideration, with particular emphasis on key areas of current interest in the field. While we continue to welcome submissions on clinically relevant research findings and innovative perspectives in the field of addiction, in 2025 and 2026 the editorial team is especially eager to receive manuscripts addressing the priority topics listed in the call for papers linked above.
From the journal's Aims & Scope
Research area (LetPub): SUBSTANCE ABUSE
Editor-in-chief Bryon AdinoffPublisher website
Editorial board by country: none in mainland China; most named India 3, Mexico 1, Argentina 1 (5 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Substance Abuse Treatment and OutcomesMedicine28.1%
- Opioid Use Disorder TreatmentMedicine11%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience5.5%
- Alcohol Consumption and Health EffectsMedicine5.4%
- HIV, Drug Use, Sexual RiskMedicine5.3%
- Homelessness and Social IssuesHealth Professions5.3%
- Prenatal Substance Exposure EffectsMedicine5.2%
- Cannabis and Cannabinoid ResearchMedicine4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Substance Abuse | Zone 3 |
| Minor | Psychology, Clinical | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Psychology, Clinical | Zone 3 |
| Minor | Substance Abuse | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Psychology, Clinical | Zone 4 |
| Minor | Substance Abuse | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · best quartile · 2025
- CiteScore Q2 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIESSCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCurrent ContentsPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.65LetPub ·
- Impact factor (publisher) 2025
- 2.6Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.8Publisher website ·
- CiteScore 2026-06
- 4.3LetPub ·
- CiteScore (publisher) 2025
- 4.3Publisher website ·
- SJR 2026-06
- 0.97LetPub ·
- SJR (publisher) 2025
- 0.97Publisher website ·
- SNIP 2026-06
- 0.95LetPub ·
- SNIP (publisher) 2025
- 0.95Publisher website ·
- h-index
- 64LetPub ·
- h-index
- 117OpenAlex ·
- i10-index
- 1,948OpenAlex ·
- 2-year mean citedness
- 2.84OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 5.83%LetPub ·
Volume
- Articles per year
- 76LetPub ·
- Downloads per year (publisher)
- 238,000Publisher website ·
Articles by year OpenAlex count · 3,039 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 49 | 16 | 11 |
| 2025 | 80 | 38 | 204 |
| 2024 | 81 | 40 | 381 |
| 2023 | 71 | 39 | 672 |
| 2022 | 71 | 26 | 895 |
| 2021 | 87 | 36 | 1,109 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
187 daysMedian, submission to acceptance · P25–P75 145 days – 257 days
- Acceptance to online
- median 36 days (88 articles)
- Submission to online
- median 233 days
- Sample
- 88 articles with submission and acceptance dates (138 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Acceptance rate (publisher)
- 30%Publisher website ·
- Submission to first decision
- 10 daysPublisher website ·
- First decision after review
- 75 daysPublisher website ·
- Acceptance to publication
- 45 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | USD 3,850 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open access
The American Journal of Drug and Alcohol Abuse is a hybrid open access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Informa Healthcare
- Country or region
- UNITED STATES
- Language
- English
- ISSN
- 0095-2990
- Electronic ISSN
- 1097-9891
- Latest issue on the website
- Volume 52, Issue 3 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
What CAS zone is AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE in?
In the 2025 upgraded edition of the CAS Journal Ranking, AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE is in Zone 3 of Medicine, and in Zone 3 of the minor category Substance Abuse / Psychology, Clinical. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE?
The latest impact factor listed by LetPub is 2.65; CiteScore 4.3, h-index 117.
How long does peer review take at AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE?
Based on the dates recorded on 88 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 187 days (interquartile range 145–257 days); the journal's website gives an acceptance rate of 30%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE in?
The journal's website gives JCR Q2 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 3 of Medicine.
Where are the editorial board members of AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE based?
Of the 5 board members whose country the journal's board page names, none are in mainland China; the countries named most often are India (3), Mexico (1) and Argentina (1). Counted from the institutions listed on the board page; for reference only.
Which databases index AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE?
According to LetPub and DOAJ records, AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE is indexed in SCIE, SSCI and Scopus. The journal's website also lists MEDLINE, PubMed, Embase and Current Contents; that list has not been checked against each database.
Is AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE open access, and what is the APC?
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE is a hybrid journal. For open-access publication: APC about USD 3,850.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .